(b)(4).Initial reporter occupation: lawyer.Dmf# 13704, trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form powder, strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Medical records received ad (b)(6) 2021 were reviewed.On (b)(6) 2014, the patient had a right total knee arthroplasty, single hamstring tendon lengthening, semimembranosus, for flexion contracture to address degenerative arthritis, varus deformity, and flexion contracture.Depuy components, including depuy patella and depuy cement x2 were used during this procedure.On (b)(6) 2019, the patient had a right revision, extensive for compartment synovectomy right knee, excision of cysts, and scar revision to address mechanical complication loosening , profound synovitis, massive cysts, debonding of the tibial tray from cement, and thickened scar tissue.Depuy components were used during this procedure, including competitor cement.During the procedure the surgeon observed cement debris.The patella was not revised.Doi: (b)(6) 2014 dor: (b)(6) 2019 (right knee).
|